Vida Ventures
Biotech Investor · 5 portfolio companies
Portfolio
5
Combined Value
$2.9B
Focus Areas
7
Top Stage
preclinical
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Dyne Therapeutics | $2.9B |
| Belharra Therapeutics | — |
| Haya Therapeutics | — |
| Iaso Bio | — |
| Alterome Therapeutics | — |